Abstract:Radiation therapy is an important cancer treatment modality in both adjuvant and definitive setting, however, the use of radiation therapy for elective treatment of regional lymph nodes is controversial for esophageal squamous cell carcinoma after radical surgery. This analysis aims to study the metastasis pattern through a pooled analysis of published results after radical tumor and lymph nodal resection with histological study in thoracic esophageal squamous cell carcinoma. Literature search using electronic databases of MEDLINE from May 1977 to April 2017 was performed, supplemented by review of references. Thirteen researches and 2531 thoracic esophageal squamous cell carcinoma patients underwent radical surgical resection were included. The probability of recurrence and metastasis in local (anastomotic and tumor bed included), lymph node and distal area was calculated. A chi-square test was used to investigate the difference by statistical software. The recurrent rate is 24.45% for locoregional, 13.23% for distal, 22.24% for lymph node, 2.44% for local. Lymph nodes is divided into cervical and supraclavicular with the recurrent rate of 12.27%, mediastinal with rate of 18.69%(upper 28.23%, middle 17.90% and lower 5.27%, respectively) and abdominal with rate of 6.10% (paraaortic 5.95% and upper abdominal 4.01% respectively). In upper thoracic esophageal squamous cell carcinoma, the order is as follows, cervical and supraclavicular with of 24.32%, mediastinal with rate of 14.86% (upper mediastinal 9.38%, middle mediastinal 3.131%, lower mediastinal 3.13%), abdominal with rate of 1.56%. In middle thoracic esophageal squamous cell carcinoma, the order is as follows, mediastinal with rate of 11.19%(upper mediastinal 7.36%, middle mediastinal 1.74%, lower mediastinal 1.74%), cervical and supraclavicular with rate of 7.12%, and abdominal with rate of 4.75%. In lower thoracic esophageal squamous cell carcinoma, the order is as follows, abdominal LN with rate of 14.85% (paraaortic 11.39% and upper abdominal 3.47%), mediastinal LN with rate of 6.93% (upper mediastinal LN 2.79%, middle mediastinal 1.68%, lower mediastinal LN 1.68%), and cervical and supraclavicular with rate of 3.47% The distal metastatic pattern is as follows, lung (7.04%), liver (6.79%), bone (4.99%), skin (2.28%), and brain (0.74%). Thoracic esophageal squamous cell carcinoma has a high propensity of lymphatic metastases but poor propensity of anastomotic and tumor bed recurrence. Cervical and supraclavicular, upper mediastinal should be delineated as the postoperative prophylactic irradiation target volume for upper, cervical and supraclavicular, upper mediastinal and abdominal lymph nodes especially paraaortic for middle, abdominal lymph nodes especially paraaortic and mediastinal lymph nodes should be delineated for lower as the postoperative prophylactic irradiation target volume.

Pattern of Relapse in Left Thoracotomy Surgical Treated Patients with Thoracic Esophageal Cancer and Their Value in Target Region Delineation in Postoperative Radiotherapy

The Value of Clinicopathologic Factors Related to Local Recurrence in Determining the Clinical Indications and Target Volume for Postoperative Radiotherapy in Patients with Thoracic Esophageal Cancer after Curative Esophagecotomy

Characteristics of the local recurrence pattern after curative resection and values in target region delineation in postoperative radiotherapy for lower thoracic esophageal squamous cell cancer.

Pattern of Recurrence in 428 Patients With Thoracic Esophageal Squamous Cell Carcinoma After Radical Surgery and Its Implication in Postoperative Radiotherapeutic Clinical Target Volume

Pattern of Locoregional Recurrence after Radical Surgery in Patients with Esophageal Squamous Cell Carcinoma and the Design of Target Volume of Postoperative Prophylactic Radiotherapy

Pattern Of Failure After Radical Surgery In Patients With Thoracic Esophageal Squamous Cell Carcinoma: Implications For Postoperative Radiation Therapy

Comparison of local recurrence patterns of esophageal carcinoma after surgery with and without postoperative radiotherapy

Significance of regions of abdominal lymph node metastasis for target volume delineation in postoperative radiotherapy for patients with recurrent esophageal carcinoma after radical surgery

The Recurrence Patterns and Post-Recurrence Survivals in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma (escc) Treated with Preoperative Paclitaxel/Cisplatin-Based Chemoradiotherapy.

Risk Factors and Patterns of Abdominal Lymph Node Recurrence After Radical Surgery for Locally Advanced Thoracic Esophageal Squamous Cell Cancer

Patterns of Failure after Radical Surgery among Patients with Thoracic Esophageal Squamous Cell Carcinoma: Implications for the Clinical Target Volume Design of Postoperative Radiotherapy.

Postoperative Intensity Modulated Radiation Therapy Improved Survival of Lymph Node-Positive or Stage III Squamous Cell Carcinoma Esophagus

A Retrospective Study to Investigate the Pattern of Local Regional Failure after Different Surgical Approaches for Thoracic Esophageal Squamous Cancer: Should the Target Volume of Postoperative Radiation Therapy Differ for Different Surgical Approaches?

Failure Patterns after Radical Surgery of Thoracic Esophageal Squamous Carcinoma

The outcomes of patients with thoracic esophageal carcinoma receiving T-shaped field adjuvant postoperative radiotherapy after left thoracotomy resection

Mapping patterns of metastatic lymph nodes for postoperative radiotherapy in thoracic esophageal squamous cell carcinoma: a recommendation for clinical target volume definition

Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma

Patterns of Regional Lymph Node Recurrence After Radical Surgery for Thoracic Esophageal Squamous Cell Carcinoma.

Postoperative lymphatic recurrence distribution and delineation of the radiation field in lower thoracic squamous cell esophageal carcinomas: a real-world study

Understanding the pattern of lymph node metastasis for trans-segmental thoracic esophageal cancer to develop precise delineation of clinical target volume for radiotherapy

Clinical Study on the Target of Prophylactic Radiotherapy after Three Field Radical Esophagectomy of Thoracic Esophageal Carcinoma